Randomized, double‐blind, placebo‐controlled 8‐week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder

Aim This study assessed the efficacy and safety of vortioxetine in adults with major depressive disorder. Methods In this double‐blind, placebo‐controlled study, 600 patients with major depressive disorder were randomly assigned (1:1:1:1) to receive vortioxetine 5, 10, or 20 mg, or placebo once dail...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Psychiatry and clinical neurosciences 2018-02, Vol.72 (2), p.64-72
Hauptverfasser:	Nishimura, Akira, Aritomi, Yutaka, Sasai, Kiyofumi, Kitagawa, Tadayuki, Mahableshwarkar, Atul R.
Format:	Artikel
Sprache:	eng
Schlagworte:	5‐HT antidepressant major depressive disorder multimodal treatment vortioxetine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!